Improvement in cardiac adrenergic function post biventricular pacing for heart failure

Europace

Volumn 9, Issue 9, 2007, Pages 751-756

  Gould, Paul A ^a   Kong, Grace ^b   Kalff, Victor ^b   Duffy, Stephen J ^b   Taylor, Andrew J ^b   Kelly, Michael J ^b   Kaye, David M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Biventricular pacing; Cardiac 123I MIBG scanning; Heart failure; Sympathetic activity

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG UPTAKE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART SCINTISCANNING; HUMAN; LONG TERM CARE; LUNG; MALE; MEDIASTINUM; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

3-IODOBENZYLGUANIDINE; AGED; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART; HEART FAILURE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RECEPTORS, ADRENERGIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 34548511802     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum081     Document Type: Article

References (44)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-50.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-53.
3. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN et al. Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA 2003; 289:730-40.
4. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
6. Vindermann M, Hennen B, Jung J, Geisel J, Bohm M, Frohlig G. Biventricular vs. conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: The Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927-37.
7. Lieberman R, Padeletti L, Schreuder J, Jackson K, Michelucci A, Colella A et al. Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. J Am Coll Cardiol 2006;48:1634-41.
8. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-70.
9. Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20:248-54.
10. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995;26:1257-63.
11. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311 819-23.
12. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, Erdner JF et al. Biventricular pacing decreases sympathetic activity compared with right ventricutar pacing in patients with depressed ejection fraction. Circulation 2000;102:1027-32.
13. Hamdan MH, Barbera S, Kawal RC, Page RL, Ramaswamy K, Joglar JA et al. Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2002;89:1047-51.
14. Grassi G, Vincenti A, Brambitia R, Trevano FQ, Dell'Oro R, Ciro A et al. Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure. Hypertension 2004;44:727-31.
15. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT, Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003;108:266-9.
16. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002; 105 1304-10.
17. Patel AD, Iskandrian AE. MIBG Imaging. J Nucl Cardiol 2002;9 75-94.
18. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39:2026-33.
19. Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies. J Nucl Cardiol 2004;11:126-33.
20. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917-23.
21. Cohen-Solal A, Esanu Y, Logeart D. Pessione F, Dubois C, Dreyfus G et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: Relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999;33:759-66.
22. Najem B, Unger P, Preumont N, Jansens JL, Houssiere A, Pathak A et al. Sympathetic control after cardiac resynchronization therapy: responders vs. nonresponders. Am J Physiol Heart Circ Physiol 2006;291:H2647-52.
23. Camici PG. Imaging of cardiac adrenergic innervation. Heart 2002;88:209-10.
24. Sato M, Maehara K, Yaota, H, Otani H, Hirosaka A, Saito T et al. Correlation between cardiac norepinephrine overflow during exercise and cardiac 123I-MIBG uptake in patients with chronic heart failure. J Nucl Med 2003;44:1618-24.
25. Merlet P, Pouillart F, Dubois-Rande JL, Delahaye N, Furney R, Castaigne A et al. Sympathetic nerve alterations assessed with 1231-MIBG in the failing human heart. J Nucl Med 1999;40:224-31.
26. Gerson MC, Craft LL, McGuire N, Suresh DP, Abraham WT, Wagoner LE. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. J Nucl Cardiol 2002;9:608-15.
27. Matsui T, Tsutamoto T, Maeda K, Kusukawa J, Kinoshita M. Prognostic value of repeated 1231-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments-comparison with neurohumoral factors. Circ J 2002;66:537-43.
28. Gerson MC, McGuire N, Wagoner LE. Sympathetic nervous system function as measured by I-123 metalodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy. J Card Fail 2003;9:384-91.
29. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 1995;26 1594-9.
30. Anastasiou-Nana MI, Terrovitis JV, Athanasoulis T, Karaloizos L, Geramoutsos A, Pappa L et al. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005;96 427-431.
31. Ohshima S, Isobe S, Izawa H, Nanasato M, Ando A, Yamada A et al. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients. J Am Coll Cardiol 2005; 46:2061-8.
32. Flevari P, Theodorakis G, Paraskevaidis I, Kolokathis F, Kostopoulou A, Leftheriotis D et al. Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart failure improvement. Europace 2006;8:44-50.
33. van Campen CM, Visser FC, van der Weerdt AP, Knaapen P, Comans EF, Lammertsma AA et al. FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging 2006;34:309-15.
34. Toyama T, Hoshizaki H, Seki R, Isobe N, Adachi H, Naito S et al. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy. J Nucl Med 2003;44 1604-11.
35. Toyama T, Hoshizaki H, Seki R, Isobe N, Adachi H, Naito S et al. Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with beta-blocker therapy. J Nucl Cardiol 2004; 11 134-41.
36. Toyama T, Aihara Y, Iwasaki T, Hasegawa A, Suzuki T, Nagai R et al. Cardiac sympathetic activity estimated by 1231-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy. J Nucl Med 1999; 40:217-23.
37. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T et al. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure. J Nucl Med 2003;44:884-90.
38. Erol-Yilmaz A, Verberne HJ, Schrama TA, Hrudova J, De Winter RJ, Eck-Smit BL et al. Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin Electrophysiol 2005;28 304-10.
39. Higuchi K, Toyama T, Tada H, Naito S, Ohshima S, Kurabayashi M. - Usefulness of biventricular pacing to improve cardiac symptoms, exercise capacity and sympathetic nerve activity in patients with moderate to severe chronic heart failure. Circ J 2006;70:703-9.
40. Slosman DO, Donath A, Alderson PO. 1311-metaiodobenzylguanidine and 1251-iodoamphetamine. Parameters of lung endothelial cell function and pulmonary vascular area. Eur J Nucl Med 1989;15:207-10.
41. Slosman DO, Polla BS, Donath A. 1231-MIBG pulmonary removal: A biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 1990; 16(8-10):633-7.
42. Koizumi T, Kubo K, Hanaoka M, Yamamoto H, Yamaguchi S, Fujii T et al. Serial scintigraphic assessment of iodine-123 metaiodobenzylguanidine lung uptake in a patient with high-attitude pulmonary edema. Chest 1999;116:1129-31.
43. Fujil T, Tanaka M, Yazaki Y, Kitabayashi H, Koizumi T, Sekiguchi M et al. Estimation of 1231-metaiodobenzylguanidine lung uptake in heart and lung diseases-with reference to lung uptake ratio and decrease of lung uptake. Kaku Igaku 1997; 34:1005-11.
44. Parthenakis FI, Prassopoulos VK, Koukouraki SI, Zacharis EA, Diakakis GF, Karkavitsas NK et al. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol 2002;9:15-22.